Synapse Open Synapse
Biology

TL1A antibodies: a new inflammatory disease market

Labiotech.eu · · 5 min read

As late-stage trials accumulate and candidates get closer to market, find out about TL1A, a new class in inflammatory diseases.

Latest from Labiotech.eu